Product Code: TMRGL85237
TMR's report on the global medical device analytical testing outsourcing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global medical device analytical testing outsourcing market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global medical device analytical testing outsourcing market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the medical device analytical testing outsourcing market.
The report delves into the competitive landscape of the global medical device analytical testing outsourcing market. Key players operating in the global medical device analytical testing outsourcing market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global medical device analytical testing outsourcing market profiled in this report.
Table of Contents
1. Executive Summary
- 1.1. Global Market Outlook
- 1.2. Demand-side Trends
- 1.3. Supply-side Trends
- 1.4. Technology Roadmap Analysis
- 1.5. Analysis and Recommendations
2. Market Overview
- 2.1. Market Coverage / Taxonomy
- 2.2. Market Definition / Scope / Limitations
3. Market Background
- 3.1. Market Dynamics
- 3.1.1. Drivers
- 3.1.2. Restraints
- 3.1.3. Opportunity
- 3.1.4. Trends
- 3.2. Scenario Forecast
- 3.2.1. Demand in Optimistic Scenario
- 3.2.2. Demand in Likely Scenario
- 3.2.3. Demand in Conservative Scenario
- 3.3. Opportunity Map Analysis
- 3.4. Product Life Cycle Analysis
- 3.5. Investment Feasibility Matrix
- 3.6. PESTLE and Porter's Analysis
- 3.7. Regulatory Landscape
- 3.7.1. By Key Regions
- 3.7.2. By Key Countries
- 3.8. Regional Parent Market Outlook
4. Global Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast, 2022-2032
- 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
- 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
- 4.2.1. Y-o-Y Growth Trend Analysis
- 4.2.2. Absolute $ Opportunity Analysis
5. Global Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Device Type
- 5.1. Introduction / Key Findings
- 5.2. Historical Market Size Value (US$ Mn) Analysis By Device Type, 2017-2021
- 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Device Type, 2022-2032
- 5.3.1. Reprocessed Devices
- 5.3.1.1. Hospital
- 5.3.1.2. Others
- 5.3.1.3. SNP Analysis
- 5.3.1.4. Mutational Analysis
- 5.3.1.5. Microarray Analysis
- 5.3.1.6. RNA Interference
- 5.3.2. Other Device Types
- 5.4. Y-o-Y Growth Trend Analysis By Device Type, 2017-2021
- 5.5. Absolute $ Opportunity Analysis By Device Type, 2022-2032
6. Global Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Service
- 6.1. Introduction / Key Findings
- 6.2. Historical Market Size Value (US$ Mn) Analysis By Service, 2017-2021
- 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Service, 2022-2032
- 6.3.1. Extractable and Leachable
- 6.3.2. Material Characterization
- 6.3.3. Physical Testing
- 6.3.4. Bioburden Testing
- 6.3.5. Sterility Testing
- 6.3.6. Other Services
- 6.4. Y-o-Y Growth Trend Analysis By Service, 2017-2021
- 6.5. Absolute $ Opportunity Analysis By Service, 2022-2032
7. Global Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Therapeutic Areas
- 7.1. Introduction / Key Findings
- 7.2. Historical Market Size Value (US$ Mn) Analysis By Therapeutic Areas, 2017-2021
- 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Therapeutic Areas, 2022-2032
- 7.3.1. Cardiology
- 7.3.2. Diagnostic Imaging
- 7.3.3. Orthopedic
- 7.3.4. IVD
- 7.3.5. Ophthalmic
- 7.3.6. General & Plastic Surgery
- 7.3.7. Drug Delivery
- 7.3.8. Endoscopy
- 7.3.9. Dental
- 7.3.10. Diabetes Care
- 7.3.11. Other Therapeutic Areass
- 7.4. Y-o-Y Growth Trend Analysis By Therapeutic Areas, 2017-2021
- 7.5. Absolute $ Opportunity Analysis By Therapeutic Areas, 2022-2032
8. Global Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By End-use
- 8.1. Introduction / Key Findings
- 8.2. Historical Market Size Value (US$ Mn) Analysis By End-use, 2017-2021
- 8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End-use, 2022-2032
- 8.3.1. Hospital
- 8.3.2. Other End-uses
- 8.4. Y-o-Y Growth Trend Analysis By End-use, 2017-2021
- 8.5. Absolute $ Opportunity Analysis By End-use, 2022-2032
9. Global Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Region
- 9.1. Introduction
- 9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
- 9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
- 9.3.1. North America
- 9.3.2. Latin America
- 9.3.3. Europe
- 9.3.4. Asia Pacific
- 9.3.5. Middle East and Africa
- 9.4. Market Attractiveness Analysis By Region
10. North America Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 10.2.1. By Country
- 10.2.1.1. U.S.
- 10.2.1.2. Canada
- 10.2.2. By Device Type
- 10.2.3. By Service
- 10.2.4. By Therapeutic Areas
- 10.2.5. By End-use
- 10.3. Market Attractiveness Analysis
- 10.3.1. By Country
- 10.3.2. By Device Type
- 10.3.3. By Service
- 10.3.4. By Therapeutic Areas
- 10.3.5. By End-use
- 10.4. Key Takeaways
11. Latin America Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 11.2.1. By Country
- 11.2.1.1. Brazil
- 11.2.1.2. Mexico
- 11.2.1.3. Rest of Latin America
- 11.2.2. By Device Type
- 11.2.3. By Service
- 11.2.4. By Therapeutic Areas
- 11.2.5. By End-use
- 11.3. Market Attractiveness Analysis
- 11.3.1. By Country
- 11.3.2. By Device Type
- 11.3.3. By Service
- 11.3.4. By Therapeutic Areas
- 11.3.5. By End-use
- 11.4. Key Takeaways
12. Europe Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 12.2.1. By Country
- 12.2.1.1. Germany
- 12.2.1.2. U.K.
- 12.2.1.3. France
- 12.2.1.4. Spain
- 12.2.1.5. Italy
- 12.2.1.6. Russia
- 12.2.1.7. Rest of Europe
- 12.2.2. By Device Type
- 12.2.3. By Service
- 12.2.4. By Therapeutic Areas
- 12.2.5. By End-use
- 12.3. Market Attractiveness Analysis
- 12.3.1. By Country
- 12.3.2. By Device Type
- 12.3.3. By Service
- 12.3.4. By Therapeutic Areas
- 12.3.5. By End-use
- 12.4. Key Takeaways
13. Asia Pacific Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 13.2.1. By Country
- 13.2.1.1. China
- 13.2.1.2. Japan
- 13.2.1.3. India
- 13.2.1.4. South Korea
- 13.2.1.5. Australia
- 13.2.1.6. Rest of APAC
- 13.2.2. By Device Type
- 13.2.3. By Service
- 13.2.4. By Therapeutic Areas
- 13.2.5. By End-use
- 13.3. Market Attractiveness Analysis
- 13.3.1. By Country
- 13.3.2. By Device Type
- 13.3.3. By Service
- 13.3.4. By Therapeutic Areas
- 13.3.5. By End-use
- 13.4. Key Takeaways
14. Middle East and Africa Medical Device Analytical Testing Outsourcing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
- 14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
- 14.2.1. By Country
- 14.2.1.1. South Africa
- 14.2.1.2. Saudi Arabia
- 14.2.1.3. UAE
- 14.2.1.4. Israel
- 14.2.1.5. Rest of MEA
- 14.2.2. By Device Type
- 14.2.3. By Service
- 14.2.4. By Therapeutic Areas
- 14.2.5. By End-use
- 14.3. Market Attractiveness Analysis
- 14.3.1. By Country
- 14.3.2. By Device Type
- 14.3.3. By Service
- 14.3.4. By Therapeutic Areas
- 14.3.5. By End-use
- 14.4. Key Takeaways
15. Key Countries Medical Device Analytical Testing Outsourcing Market Analysis
- 15.1. U.S.
- 15.1.1. Pricing Analysis
- 15.1.2. Market Share Analysis, 2021
- 15.1.2.1. By Device Type
- 15.1.2.2. By Service
- 15.1.2.3. By Therapeutic Areas
- 15.1.2.4. By End-use
- 15.2. Canada
- 15.2.1. Pricing Analysis
- 15.2.2. Market Share Analysis, 2021
- 15.2.2.1. By Device Type
- 15.2.2.2. By Service
- 15.2.2.3. By Therapeutic Areas
- 15.2.2.4. By End-use
- 15.3. Brazil
- 15.3.1. Pricing Analysis
- 15.3.2. Market Share Analysis, 2021
- 15.3.2.1. By Device Type
- 15.3.2.2. By Service
- 15.3.2.3. By Therapeutic Areas
- 15.3.2.4. By End-use
- 15.4. Mexico
- 15.4.1. Pricing Analysis
- 15.4.2. Market Share Analysis, 2021
- 15.4.2.1. By Device Type
- 15.4.2.2. By Service
- 15.4.2.3. By Therapeutic Areas
- 15.4.2.4. By End-use
- 15.5. Germany
- 15.5.1. Pricing Analysis
- 15.5.2. Market Share Analysis, 2021
- 15.5.2.1. By Device Type
- 15.5.2.2. By Service
- 15.5.2.3. By Therapeutic Areas
- 15.5.2.4. By End-use
- 15.6. U.K.
- 15.6.1. Pricing Analysis
- 15.6.2. Market Share Analysis, 2021
- 15.6.2.1. By Device Type
- 15.6.2.2. By Service
- 15.6.2.3. By Therapeutic Areas
- 15.6.2.4. By End-use
- 15.7. France
- 15.7.1. Pricing Analysis
- 15.7.2. Market Share Analysis, 2021
- 15.7.2.1. By Device Type
- 15.7.2.2. By Service
- 15.7.2.3. By Therapeutic Areas
- 15.7.2.4. By End-use
- 15.8. Spain
- 15.8.1. Pricing Analysis
- 15.8.2. Market Share Analysis, 2021
- 15.8.2.1. By Device Type
- 15.8.2.2. By Service
- 15.8.2.3. By Therapeutic Areas
- 15.8.2.4. By End-use
- 15.9. Italy
- 15.9.1. Pricing Analysis
- 15.9.2. Market Share Analysis, 2021
- 15.9.2.1. By Device Type
- 15.9.2.2. By Service
- 15.9.2.3. By Therapeutic Areas
- 15.9.2.4. By End-use
- 15.10. Russia
- 15.10.1. Pricing Analysis
- 15.10.2. Market Share Analysis, 2021
- 15.10.2.1. By Device Type
- 15.10.2.2. By Service
- 15.10.2.3. By Therapeutic Areas
- 15.10.2.4. By End-use
- 15.11. China
- 15.11.1. Pricing Analysis
- 15.11.2. Market Share Analysis, 2021
- 15.11.2.1. By Device Type
- 15.11.2.2. By Service
- 15.11.2.3. By Therapeutic Areas
- 15.11.2.4. By End-use
- 15.12. Japan
- 15.12.1. Pricing Analysis
- 15.12.2. Market Share Analysis, 2021
- 15.12.2.1. By Device Type
- 15.12.2.2. By Service
- 15.12.2.3. By Therapeutic Areas
- 15.12.2.4. By End-use
- 15.13. India
- 15.13.1. Pricing Analysis
- 15.13.2. Market Share Analysis, 2021
- 15.13.2.1. By Device Type
- 15.13.2.2. By Service
- 15.13.2.3. By Therapeutic Areas
- 15.13.2.4. By End-use
- 15.14. South Korea
- 15.14.1. Pricing Analysis
- 15.14.2. Market Share Analysis, 2021
- 15.14.2.1. By Device Type
- 15.14.2.2. By Service
- 15.14.2.3. By Therapeutic Areas
- 15.14.2.4. By End-use
- 15.15. Australia
- 15.15.1. Pricing Analysis
- 15.15.2. Market Share Analysis, 2021
- 15.15.2.1. By Device Type
- 15.15.2.2. By Service
- 15.15.2.3. By Therapeutic Areas
- 15.15.2.4. By End-use
- 15.16. South Africa
- 15.16.1. Pricing Analysis
- 15.16.2. Market Share Analysis, 2021
- 15.16.2.1. By Device Type
- 15.16.2.2. By Service
- 15.16.2.3. By Therapeutic Areas
- 15.16.2.4. By End-use
- 15.17. Saudi Arabia
- 15.17.1. Pricing Analysis
- 15.17.2. Market Share Analysis, 2021
- 15.17.2.1. By Device Type
- 15.17.2.2. By Service
- 15.17.2.3. By Therapeutic Areas
- 15.17.2.4. By End-use
- 15.18. UAE
- 15.18.1. Pricing Analysis
- 15.18.2. Market Share Analysis, 2021
- 15.18.2.1. By Device Type
- 15.18.2.2. By Service
- 15.18.2.3. By Therapeutic Areas
- 15.18.2.4. By End-use
- 15.19. Israel
- 15.19.1. Pricing Analysis
- 15.19.2. Market Share Analysis, 2021
- 15.19.2.1. By Device Type
- 15.19.2.2. By Service
- 15.19.2.3. By Therapeutic Areas
- 15.19.2.4. By End-use
16. Market Structure Analysis
- 16.1. Competition Dashboard
- 16.2. Competition Benchmarking
- 16.3. Market Share Analysis of Top Players
- 16.3.1. By Regional
- 16.3.2. By Device Type
- 16.3.3. By Service
- 16.3.4. By Therapeutic Areas
- 16.3.5. By End-use
17. Competition Analysis
- 17.1. Competition Deep Dive
- 17.1.1. SGS SA
- 17.1.1.1. Overview
- 17.1.1.2. Product Portfolio
- 17.1.1.3. Profitability by Market Segments
- 17.1.1.4. Sales Footprint
- 17.1.1.5. Strategy Overview
- 17.1.1.5.1. Marketing Strategy
- 17.1.2. Toxikon, Inc.
- 17.1.2.1. Overview
- 17.1.2.2. Product Portfolio
- 17.1.2.3. Profitability by Market Segments
- 17.1.2.4. Sales Footprint
- 17.1.2.5. Strategy Overview
- 17.1.2.5.1. Marketing Strategy
- 17.1.3. Eurofins Scientific
- 17.1.3.1. Overview
- 17.1.3.2. Product Portfolio
- 17.1.3.3. Profitability by Market Segments
- 17.1.3.4. Sales Footprint
- 17.1.3.5. Strategy Overview
- 17.1.3.5.1. Marketing Strategy
- 17.1.4. Pace Analytical Services LLC
- 17.1.4.1. Overview
- 17.1.4.2. Product Portfolio
- 17.1.4.3. Profitability by Market Segments
- 17.1.4.4. Sales Footprint
- 17.1.4.5. Strategy Overview
- 17.1.4.5.1. Marketing Strategy
- 17.1.5. Intertek Group plc
- 17.1.5.1. Overview
- 17.1.5.2. Product Portfolio
- 17.1.5.3. Profitability by Market Segments
- 17.1.5.4. Sales Footprint
- 17.1.5.5. Strategy Overview
- 17.1.5.5.1. Marketing Strategy
- 17.1.6. Wuxi AppTec
- 17.1.6.1. Overview
- 17.1.6.2. Product Portfolio
- 17.1.6.3. Profitability by Market Segments
- 17.1.6.4. Sales Footprint
- 17.1.6.5. Strategy Overview
- 17.1.6.5.1. Marketing Strategy
- 17.1.7. Envigo
- 17.1.7.1. Overview
- 17.1.7.2. Product Portfolio
- 17.1.7.3. Profitability by Market Segments
- 17.1.7.4. Sales Footprint
- 17.1.7.5. Strategy Overview
- 17.1.7.5.1. Marketing Strategy
- 17.1.8. Charles River Laboratories
- 17.1.8.1. Overview
- 17.1.8.2. Product Portfolio
- 17.1.8.3. Profitability by Market Segments
- 17.1.8.4. Sales Footprint
- 17.1.8.5. Strategy Overview
- 17.1.8.5.1. Marketing Strategy
- 17.1.9. Medical Device Testing Services
- 17.1.9.1. Overview
- 17.1.9.2. Product Portfolio
- 17.1.9.3. Profitability by Market Segments
- 17.1.9.4. Sales Footprint
- 17.1.9.5. Strategy Overview
- 17.1.9.5.1. Marketing Strategy
18. Assumptions & Acronyms Used
19. Research Methodology